Oligomenorrhoea. Secondary Oligomenorrhoea
Conditions
Interventions
Intervention 1: . Intervention 2: Intervention group:.
Sponsors
Traditional Medicine and Materia Medica Research Center
Eligibility
Sex/Gender
All
Age
18 Years to 40 Years
Inclusion criteria
Inclusion criteria: All women with PCO who present with an oligomenorrhea complaint and consent to the study
Exclusion criteria
Exclusion criteria: People with any type of systemic disease such as diabetes, Cushing's, adrenal hyperplasia, hyperprolactin, hyper thyroidism Pregnant women and women who are breastfeeding (the first 6 months) are either planning to become pregnant or women who have had an abortion People taking hormonal medications, including LD pills People with a history of breast and ovarian cancer and people undergoing chemotherapy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The effect of “ma_ol_asal”syrup on the duration of bleeding in patients with polycystic ovary syndrome. Timepoint: Before entering the study and after the treatment period. Method of measurement: Question from the patient.;The effect of “ma_ol_asal” syrup on bleeding rate in patients with polycystic ovary syndrome. Timepoint: Before entering the study and after the treatment period. Method of measurement: Pictorial Bleeding Assessment Chart (PBAC).;The effect of “ma_ol_asal” syrup on BMI in patients with polycystic ovary syndrome. Timepoint: Before entering the study and after the treatment period. Method of measurement: Meters and scales and BMI formula. | — |
Secondary
| Measure | Time frame |
|---|---|
| Menstrual period. Timepoint: Before entering the study and after the treatment period. Method of measurement: Question from the patient.;Cleanliness period. Timepoint: Before entering the study and after the treatment period. Method of measurement: Question from the patient. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHanieh Babaei
Shahid Beheshti School of Traditional Medicine
Outcome results
None listed